Table 7 Clinical details of subjects.

From: Genetic regulation of disease risk and endometrial gene expression highlights potential target genes for endometriosis and polycystic ovarian syndrome

 

Group 1 (RWH)

Group 2 (IVF)

Number of samples

165

64

Age (years ± SEM)

31.21 ± 0.53

36.56 ± 0.51

Endometriosis

Diagnosis methods

Surgically confirmed

Self-report

Diagnosis

    Yes

67.9% (112/165)

32.8% (21/64)

    No

29.1% (48/165)

64.1% (41/64)

    Unknown

3.0% (5/165)

3.1% (2/64)

Uterine fibroids

Diagnosis

    Yes

6.1% (10/165)

    No

30.9% (51/165)

    Unknown

63.0% (104/165)

100% (64/64)

Adenomyosis

Diagnosis

    Yes

9.7% (16/165)

    No

26.1% (43/165)

    Unknown

64.2% (106/165)

100% (64/64)

Histological cycle staging

    Menstrual (M)

6.7% (11/165)

0% (0/64)

    Early proliferative (EP)

3.0% (5/165)

0% (0/64)

    Mid proliferative (MP)

39.4% (65/165)

6.3% (4/64)

    Late proliferative (LP)

9.7% (16/165)

6.3% (4/64)

    Early secretory (ES)

9.7% (16/165)

53.0% (34/64)

    Mid secretory (MS)

17.6% (29/165)

34.4% (22/64)

    Late secretory (LS)

13.9% (23/165)

0% (0/64)

Back to article page